Junshi Biosciences Announces the Acceptance of the Supplemental New Drug Application for Toripalimab Combined with Bevacizumab for the First-Line Treatment of Advanced Hepatocellular Carcinoma 18-07-2024, 10:38

BlueCat enters agreement to acquire LiveAction to broaden its portfolio of network infrastructure management solutions 3-10-2024, 23:00

Colliers joins the World Green Building Council’s Net Zero Carbon Buildings Commitment 7-12-2023, 19:15